Sources | Names Used |
---|---|
CTRPv2 | selumetinib:tretinoin (2:1 mol/mol) |
PharmacoGx | selumetinib:tretinoin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZFP36L2 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-15 |
mRNA | IRF2BP2 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-15 |
mRNA | LYST | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-14 |
mRNA | CFD | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-14 |
mRNA | MYO1F | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-14 |
mRNA | CEBPA | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-13 |
mRNA | TMEM105 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-13 |
mRNA | PLPPR3 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-12 |
mRNA | HRH2 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
mRNA | PARVG | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-12 |